J Gen Virol Try IJSEM Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 13 (1971), 485-489; DOI 10.1099/0022-1317-13-3-485
© 1971 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tovell, D.
Right arrow Articles by Cantell, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tovell, D.
Right arrow Articles by Cantell, K.
Agricola
Right arrow Articles by Tovell, D.
Right arrow Articles by Cantell, K.

Kinetics of Interferon Production in Human Leukocyte Suspensions

Dorothy Tovell and K. Cantell

State Serum Institute, Helsinki, Finland

The amount of interferon obtained from a given number of human leukocytes is limited by the fact that synthesis occurs for only 8 to 10 hr after induction by Sendai virus, and the cells are then refractory to further stimulation (Strander & Cantell, 1967). The factors which limit interferon synthesis and control development of the refractory state are not understood. This paper describes the effect on both the final yield and the kinetics of interferon production of adjusting conditions of incubation such as pH and temperature, and of priming with virus or interferon before induction.

The procedures used in purification of leukocytes and production of interferon have been published in detail (Strander & Cantell, 1966, 1967). The cells were suspended in Eagle's minimal essential medium (MEM) buffered with 3 mg./ml. of N-tris(hydroxymethyl)methyl glycine (Tricine, obtained from Calbiochem, Los Angeles, California) instead of phosphate, and the suspensions were supplemented with 5% inactivated (30 min. at 56°) human serum.

Received 15 March 1971; accepted 31 August 1971.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1971 by the Society for General Microbiology.